XOMA Appoints CFO

Thomas Burns has been appointed chief financial officer, XOMA Corp. He succeeds Fred Kurland who retires from his role as vice president, finance, chief financial officer and secretary, effective April 3, 2015. Mr. Burns will report to John Varian, chief executive officer.
 
“Fred has been an integral part of the team that has established XOMA as a leader in the discovery and development of therapeutic antibodies. He has ensured we have the capital we need to advance gevokizumab towards XOMA’s first Biologics Licensing Application and expand our clinical development pipeline,” said Mr. Varian. “Tom has been with XOMA for 8 years, and he has grown significantly under Fred’s mentorship. This promotion is well deserved, as Tom has shown he has all of the necessary skills to be a very successful CFO.”
 
Mr. Burns joined the company in 2006 and has played an important role in financing and financial reporting activities. Prior to XOMA, he held multiple senior financial management positions at Mattson Technology, IntruVert Networks (acquired by McAfee), Niku Corp. (acquired by Computer Associates) and Conner Technology.